Qiming-Backed AI Drug Discovery Startup Insilico Medicine Files For Hong Kong IPO Insilico Medicine was valued at about $895 million after raising $95 million last July from the likes of leading Chinese healthcare-focused firm Qiming Venture Partners and billionaire Eduardo Saverin’s B Capital, among others.